Updated Jul 16, 2026
Taylor Andrew Lawrence has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 36.4K | $4.02 | $146K |
| 2026-05-29 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 3.1K | $3.98 | $12K |
| 2026-02-13 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 181.0K | $0.00 | |
| 2025-09-17 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 16.1K | $2.46 | $40K |
| 2025-08-25 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 2.0K | $2.55 | $5K |
| 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 80.0K | $0.00 | |
| 2024-12-20 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 1.0K | $4.83 | $5K |
| 2024-12-13 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 34.4K | $5.03 | $173K |
Taylor Andrew Lawrence is a corporate insider — currently tracked as Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Taylor Andrew Lawrence profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.